Auris Medical Nasdaq

At Manningham Medical Centre, you can find all the data about Auris Medical Nasdaq. We have collected data about general practitioners, medical and surgical specialists, dental, pharmacy and more. Please see the links below for the information you need.

Auris Medical Acquires RNA Therapeutics Company …

https://www.nasdaq.com/articles/auris-medical-acquires-rna-therapeutics-company-trasir-therapeutics-quick-facts-2021-06-03

(RTTNews) - Clinical-stage company Auris Medical Holding Ltd. (EARS) announced Thursday that it has acquired privately-held RNA Therapeutics Company …

Auris Medical Holding Ltd. Prices $8,000,000 Common …

https://www.nasdaq.com/press-release/auris-medical-holding-ltd.-prices-%248000000-common-shares-offering-priced-at-the

Hamilton, Bermuda, December 2, 2020 – Auris Medical Holding Ltd. (NASDAQ: EARS) (“Auris” or the “Company”), a clinical-stage company dedicated to …

Auris Medical Announces Initiation of Clinical …

https://www.nasdaq.com/press-release/auris-medical-announces-initiation-of-clinical-investigation-of-am-301-in-allergic

Hamilton, Bermuda, January 29, 2021 – Auris Medical Holding Ltd. (NASDAQ: EARS), a clinical-stage company dedicated to developing therapeutics that …

Auris Medical Announces Launch of New Corporate Website

https://finance.yahoo.com/news/auris-medical-announces-launch-corporate-130000220.html

Auris Medical AG. Hamilton, Bermuda, July 15, 2021 – Auris Medical Holding Ltd. (NASDAQ: EARS), a company dedicated to addressing unmet medical …

Auris Medical Announces Initiation of Part B of …

https://www.nasdaq.com/press-release/auris-medical-announces-initiation-of-part-b-of-travers-phase-2-study-with-am-125-in

Hamilton, Bermuda, October 13, 2020– Auris Medical Holding Ltd., a clinical-stage company dedicated to developing therapeutics that address important …

Auris Medical Announces Positive Preclinical and …

https://www.nasdaq.com/press-release/auris-medical-announces-positive-preclinical-and-clinical-outcomes-with-am-301-and

Clinical evaluation of AM-301 nasal spray in allergic rhinitis meets primary endpoint Extended protection achieved over several hours Preliminary preclinical data …

Auris Medical Provides Update on Bentrio Program in …

https://www.nasdaq.com/press-release/auris-medical-provides-update-on-bentrio-program-in-allergy-2021-05-07

Auris Medical is a clinical-stage company dedicated to developing therapeutics that address important unmet medical needs in neurotology, rhinology and …

Auris Medical Announces Initiation of Clinical

https://www.globenewswire.com/news-release/2021/01/29/2166613/0/en/Auris-Medical-Announces-Initiation-of-Clinical-Investigation-of-AM-301-in-Allergic-Rhinitis.html

Hamilton, Bermuda, January 29, 2021 – Auris Medical Holding Ltd. (NASDAQ: EARS), a clinical-stage company dedicated to developing therapeutics that …

Auris Medical Receives FDA and EMA Guidance for …

https://www.nasdaq.com/press-release/auris-medical-receives-fda-and-ema-guidance-for-keyzilenr-late-stage-clinical

Auris Medical is a biopharmaceutical company dedicated to developing therapeutics that address important unmet medical needs in neurotology and central …

Auris Medical Announces Publication of AM-111 Phase 3 …

https://www.nasdaq.com/press-release/auris-medical-announces-publication-am-111-phase-3-results-peer-reviewed-scientific

The Company was founded in 2003 and is headquartered in Zug, Switzerland. The shares of Auris Medical Holding AG trade on the NASDAQ Capital …

Need more information about Auris Medical Nasdaq?

At Manningham Medical Centre, we collected data on more than just Auris Medical Nasdaq. There is a lot of other useful information. Visit the related pages or our most popular pages. Also check out our Doctors page.